All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

C-13-methacetin breath test in the evaluation of disease severity in patients with liver cirrhosis

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F13%3A33147367" target="_blank" >RIV/61989592:15110/13:33147367 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11120/13:43907709 RIV/68407700:21460/13:00217378 RIV/00064173:_____/13:N0000018

  • Result on the web

    <a href="http://dx.doi.org/10.5507/bp.2012.114" target="_blank" >http://dx.doi.org/10.5507/bp.2012.114</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.5507/bp.2012.114" target="_blank" >10.5507/bp.2012.114</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    C-13-methacetin breath test in the evaluation of disease severity in patients with liver cirrhosis

  • Original language description

    Aims: The non-invasive 13C-methacetin (13C-MBT) breath test has been proposed as a measure of metabolic liver function that improves the diagnostic efficacy of serologic and biochemical tests in assessing hepatic functional capacity and liver disease severity, The goal of this study was to establish the clinical utility of this test in quantifying hepatic metabolic function in patients with liver cirrhosis of varying severity and to compare 13C-MBT measurements with the AST/ALT ratio, APRI score, and other routine liver tests. Methods: Routine liver function tests including serum bilirubin, aspartate aminotransferase activity (AST), alanine aminotransferase (ALT), AST/ALT ratio, the APRI score, the percentage of dose rate (PDR) and cumulative percentage of dose rate (CPDR) of the 13C-MBT were evaluated in 52 cirrhotic patients of alcohol etiology (Child-Pugh A/B/C 10/28/14) and 37 healthy controls. Results: The 13C-MBT differed significantly between healthy controls and cirrhotic patie

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FE - Other fields of internal medicine

  • OECD FORD branch

Result continuities

  • Project

    <a href="/en/project/ED0030%2F01%2F01" target="_blank" >ED0030/01/01: Biomedicine for regional development and human resources</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2013

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Biomedical Papers-Olomouc

  • ISSN

    1213-8118

  • e-ISSN

  • Volume of the periodical

    157

  • Issue of the periodical within the volume

    4

  • Country of publishing house

    CZ - CZECH REPUBLIC

  • Number of pages

    9

  • Pages from-to

    392-400

  • UT code for WoS article

    000329091500021

  • EID of the result in the Scopus database